Current progress in the inflammatory background of angiogenesis in gynecological cancers Grzegorz SzewczykTomasz M. MaciejewskiDariusz Szukiewicz Review Open access 24 January 2019 Pages: 247 - 260
Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy study David L. BoyleSamuel E. DePrimoRobin L. Thurmond Original Research Paper 09 February 2019 Pages: 261 - 274
The influence of ICAM1 rs5498 on diabetes mellitus risk: evidence from a meta-analysis Wensheng MiYan XiaYanhui Bian Original Research Paper 23 February 2019 Pages: 275 - 284
Celastrol suppresses experimental autoimmune encephalomyelitis via MAPK/SGK1-regulated mediators of autoimmune pathology Shivaprasad H. VenkateshaKamal D. Moudgil Original Research Paper 28 February 2019 Pages: 285 - 296
Artemisinin and its derivatives: a potential therapeutic approach for oral lichen planus Rui-Jie MaMing-Jing HeGang Zhou Original Research Paper 01 February 2019 Pages: 297 - 310
Bazedoxifene protects cerebral autoregulation after traumatic brain injury and attenuates impairments in blood–brain barrier damage: involvement of anti-inflammatory pathways by blocking MAPK signaling Yu-Long LanXun WangBo Zhang Original Research Paper 31 January 2019 Pages: 311 - 323
EZH2 plays a crucial role in ischemia/reperfusion-induced acute kidney injury by regulating p38 signaling Hua LiangQiong HuangHong-zhen Liu Original Research Paper 28 February 2019 Pages: 325 - 336
AIM2 levels and DNA-triggered inflammasome response are increased in peripheral leukocytes of patients with abdominal aortic aneurysm Markus WortmannXianghui XiaoSusanne Dihlmann Original Research Paper 13 February 2019 Pages: 337 - 345